Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection
Editorial Group: Cochrane HIV/AIDS Group
Published Online: 9 NOV 2011
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Cruciani M, Martí-Carvajal AJ, Mengoli C, Serpelloni G, Bovo C, Moyle G. Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 11. Art. No.: CD009390. DOI: 10.1002/14651858.CD009390.
- Publication Status: New
- Published Online: 9 NOV 2011
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the clinical effectiveness and safety of the combined Antiretroviral Treatment containing ABC relative to ABC-sparing cART. A subgroup comparison will be performed in studies comparing Antiretroviral Treatment containing ABC relative to TDF containing cART.